Display options
Cite
Barone MA, Li PS, Awori QD, et al. Clinical trials using the Shang Ring device for male circumcision in Africa: a review. Transl Androl Urol. 2014;3(1):113-24doi: 10.3978/j.issn.2223-4683.2014.01.09.
Barone, M. A., Li, P. S., Awori, Q. D., Lee, R., & Goldstein, M. (2014). Clinical trials using the Shang Ring device for male circumcision in Africa: a review. Translational andrology and urology, 3(1), 113-24. https://doi.org/10.3978/j.issn.2223-4683.2014.01.09
Barone, Mark A, et al. "Clinical trials using the Shang Ring device for male circumcision in Africa: a review." Translational andrology and urology vol. 3,1 (2014): 113-24. doi: https://doi.org/10.3978/j.issn.2223-4683.2014.01.09
Barone MA, Li PS, Awori QD, Lee R, Goldstein M. Clinical trials using the Shang Ring device for male circumcision in Africa: a review. Transl Androl Urol. 2014 Mar;3(1):113-24. doi: 10.3978/j.issn.2223-4683.2014.01.09. PMID: 26816759; PMCID: PMC4708291.
Copy Download .nbib Format: NLM
Share it on

Transl Androl Urol. 2014 Mar;3(1):113-24. doi: 10.3978/j.issn.2223-4683.2014.01.09.

Clinical trials using the Shang Ring device for male circumcision in Africa: a review.

Translational andrology and urology

Mark A Barone, Philip S Li, Quentin D Awori, Richard Lee, Marc Goldstein

Affiliations

  1. 1 EngenderHealth, New York, NY, USA ; 2 Center for Male Reproductive Medicine and Microsurgery, Department of Urology, Weill Cornell Medical College, New York, NY, USA ; 3 EngenderHealth, Nairobi, Kenya.

PMID: 26816759 PMCID: PMC4708291 DOI: 10.3978/j.issn.2223-4683.2014.01.09

Abstract

Male circumcision (MC) reduces the risk of HIV and other sexually transmitted infections (STIs), including human papillomavirus (HPV) and herpes simplex virus type 2 (HSV-2), and is recommended as an important component of a comprehensive package of HIV prevention interventions. While computer modeling has demonstrated that substantial reductions in HIV could be achieved with rapid scale-up of MC services in sub-Saharan Africa, scale-up has lagged due to scarcity of trained providers coupled with relative technical difficulty of recommended surgical MC techniques. Simplified techniques, such as devices, have the potential to allow for a more rapid roll-out of MC. One such device is the Shang Ring, a novel disposable MC device that eliminates the need for suturing and has been on the Chinese market since 2005. Results from Chinese studies have demonstrated that the Shang Ring is both safe and easy to use. Since 2008, a series of studies using the Shang Ring for adult MC have been carried out in Kenya, Uganda and Zambia, according to guidelines established by World Health Organization (WHO) for clinical evaluation of new devices for adult MC. These include a proof of concept study, a study of delayed removal of the Shang Ring, two studies comparing Shang Ring circumcision to conventional surgical approaches, and a large field trial to evaluate safety of Shang Ring circumcision during routine service delivery. Results from these studies demonstrate that the Shang Ring has an excellent safety profile and that Shang Ring circumcision is relatively easy to teach and learn, making Shang Ring MC an appealing technique for use in sub-Saharan Africa where doctors are in short supply and non-physician providers such as nurses and clinical officers are playing a major role in providing MC through task shifting. Shang Ring MC and device removals were uneventfully performed by trained nurses and clinical officers, who preferred the Shang Ring to conventional surgical techniques. Adverse event rates were similar to those observed with conventional surgical circumcision and were managed with, at most, minor interventions, resolving with no long-term sequale. Perhaps one of the biggest advantages of the Shang Ring is the relatively short 3-6 minutes procedure time. Importantly, men also preferred the Shang Ring compared to conventional circumcision and satisfaction with cosmetic appearance of their circumcised penis was very high. The vast majority of participants in studies in Africa as well as China have reported few problems and little disruption to daily life while wearing the device. The Shang Ring holds great promise as an innovative technology that has the potential to facilitate the safe and effective scale-up of circumcision services in settings where MC is not widely used and where the burden of HIV-disease is high.

Keywords: HIV prevention; Shang Ring; male circumcision (MC)

References

  1. Nat Rev Urol. 2010 Nov;7(11):638-42 - PubMed
  2. Sex Transm Infect. 2013 May;89(3):262-6 - PubMed
  3. Clin Infect Dis. 2011 Dec;53 Suppl 3:S64-78 - PubMed
  4. Int J Cancer. 2013 Sep 1;133(5):1247-52 - PubMed
  5. J Acquir Immune Defic Syndr. 2013 Aug 15;63(5):617-21 - PubMed
  6. BMC Infect Dis. 2011 Sep 26;11:253 - PubMed
  7. J Acquir Immune Defic Syndr. 2013 Oct 1;64(2):130-3 - PubMed
  8. Int J Cancer. 2012 Apr 15;130(8):1888-97 - PubMed
  9. Urology. 2010 Oct;76(4):810-4 - PubMed
  10. Asian J Androl. 2008 May;10(3):447-54 - PubMed
  11. Am J Obstet Gynecol. 2009 Jan;200(1):42.e1-7 - PubMed
  12. BMC Infect Dis. 2007 Mar 13;7:16 - PubMed
  13. PLoS Med. 2010 Jul 20;7(7):e1000309 - PubMed
  14. Lancet. 2007 Feb 24;369(9562):643-56 - PubMed
  15. Lancet. 2007 Feb 24;369(9562):657-66 - PubMed
  16. Int J STD AIDS. 1996 Oct;7(6):410-4 - PubMed
  17. PLoS Med. 2005 Nov;2(11):e298 - PubMed
  18. S Afr Med J. 2009 Mar;99(3):163-9 - PubMed
  19. Sex Transm Dis. 2012 Feb;39(2):104-13 - PubMed
  20. J Acquir Immune Defic Syndr. 2013 Oct 1;64(2):e11 - PubMed
  21. PLoS Med. 2009 Sep;6(9):e1000109 - PubMed
  22. J Infect Dis. 2010 May 15;201(10):1463-9 - PubMed
  23. Urology. 2011 Jul;78(1):174-9 - PubMed
  24. Zhonghua Nan Ke Xue. 2010 Apr;16(4):325-7 - PubMed
  25. Zhonghua Nan Ke Xue. 2009 Jul;15(7):584-92 - PubMed
  26. Science. 2008 May 9;320(5877):749-50 - PubMed
  27. J Acquir Immune Defic Syndr. 2011 May 1;57(1):e7-12 - PubMed
  28. J Acquir Immune Defic Syndr. 2012 Sep 1;61(1):49-55 - PubMed
  29. PLoS One. 2008 May 21;3(5):e2212 - PubMed
  30. J Acquir Immune Defic Syndr. 2014 Apr 1;65(4):447-55 - PubMed
  31. PLoS One. 2008 Aug 06;3(8):e2679 - PubMed
  32. Urol Int. 2007;78(3):235-40 - PubMed
  33. J Acquir Immune Defic Syndr. 2012 Jul 1;60(3):e82-9 - PubMed
  34. AIDS. 2012 Mar 13;26(5):609-15 - PubMed
  35. Lancet. 2011 Jan 15;377(9761):209-18 - PubMed
  36. Lancet. 2008 Aug 16;372(9638):585-99 - PubMed
  37. PLoS Med. 2011 Nov;8(11):e1001132 - PubMed
  38. AIDS. 2008 Mar 12;22(5):567-74 - PubMed
  39. J Infect Dis. 2009 Jan 1;199(1):14-9 - PubMed
  40. Lancet. 1999 Nov 20;354(9192):1813-5 - PubMed
  41. AIDS. 2008 Sep 12;22(14):1841-50 - PubMed

Publication Types